Search Results
136 items found for "Brian Bender"
- Serotonin Receptor 5-HT2A Regulates TrkB Receptor Function in Heteroreceptor Complexes
accordance with our findings demonstrating the prevalence of 5-HT2A–TrkB heteroreceptor complexes in these brain especially the striatum, demonstrating that the balance between TrkB and 5-HT2A may shift in certain brain heterodimerization and suggest that the regulated expression of 5-HT2A and TrkB is a molecular mechanism for the brain-region-specific
- A cryptic mode of GPCR regulation revealed
mutation of C265 augments β2AR protein kinase A signaling, enables β2AR nitric oxide (NO) signaling, renders
- 📰 GPCR Weekly News, March 13 to 19, 2023
GPCR Binders, Drugs, and more Design of Drug Efficacy Guided by Free Energy Simulations of the β2-Adrenoceptor GPCRs in Neuroscience Physiological Condition-Dependent Changes in Ciliary GPCR Localization in the Brain
- 📰 GPCR Weekly News, April 22 to 28, 2024
determinants thereof Ubiquitin-driven G Protein-Coupled Receptor Inflammatory Signaling at the Endosome GPCR Binders INSL5 chimeric peptide ligand for NanoBiT complementation binding assays Generation of a deep mouse brain
- A central alarm system that gates multi-sensory innate threat cues to the amygdala
parallel pathways independently relay innate threat signals from different sensory modalities to multiple brain innate threat cues are integrated and conveyed from each sensory modality to the amygdala, a critical brain
- 📰 GPCR Weekly News
GPCR Binders, Drugs, and more Altered signaling at the PTH receptor via modified agonist contacts with Superconserved receptors expressed in the brain: Expression, function, motifs and evolution of an orphan
- 📰 GPCR Weekly News, July 1 to 7, 2024
potential of a GPCR for arrestin-biased agonism The roles of RGS proteins in cardiometabolic disease GPCR Binders receptors GPCRs in Neuroscience Neuron specific quantitation of Gαolf expression and signaling in murine brain
- 📰 GPCR Weekly News, May 29 to June 4, 2023
GPCR Binders, Drugs, and more ACE2 Activation by Tripeptide IRW (Ile-Arg-Trp) Depends on the G Protein-Coupled Methods & Updates in GPCR Research Illuminating the brain-genetically encoded single wavelength fluorescent
- Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases
September 2022 "Glutamate is the primary excitatory neurotransmitter in the brain and plays critical orthosteric and allosteric ligands acting on either mGluR2, mGluR3 or both for the management of these brain
- 📰 GPCR Weekly News, October 30 to November 4, 2023
supplementation regulates the fat deposition in adipose tissues of finishing pigs via cAMP/PKA pathway GPCR Binders Therapy Research Structure Therapeutics Receives R&D Achievement of the Year Award for GPCR Research Bryan
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
September 2022 Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain electrophysiological studies, indicate that CB2 receptors are expressed in specific dopaminergic and glutamatergic brain
- G-protein-coupled receptors as therapeutic targets for glioblastoma
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumour in adults. Despite this, the prognosis remains poor, with an impacted quality of life during treatment coupled with brain
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
discovery programs in key therapeutic areas Kallyope, pioneers in drug discovery involving the gut-brain biopharmaceutical company, and New York City-based Kallyope, pioneers in drug discovery involving the gut-brain
- 📰 GPCR Weekly News, February 19 to 25, 2024
wounding, a G-protein coupled receptor promotes the restoration of tension in epithelial cells GPCR Binders Species-Specific Duplicated FMRFaR-like Gene A62 Regulates Spontaneous Locomotion in Apolygus lucorum Whole Brain
- 📰 GPCR Weekly News, January 29 to February 4, 2024
GRK5 promoted renal fibrosis via HDAC5/Smad3 signaling pathway Non-canonical G protein signaling GPCR Binders perspectives of GPCR-based genetically encoded fluorescent indicators for neuromodulators Illuminating the brain-genetically
- Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas ...
functions distinct from odor perception, and may contribute to the pathogenesis of disorders including brain Glioma is the most common adult malignant brain tumor and requires novel therapeutic strategies to improve Here, we outlined the expression of brain ORs and investigated OR expression levels in glioma.
- 📰 GPCR Weekly News, February 6 to 12, 2023
Isoform- and ligand-specific modulation of the adhesion GPCR ADGRL3/Latrophilin3 by a synthetic binder GPCR Binders, Drugs, and more An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical
- Diversity and specificity in location-based signaling outputs of neuronal GPCRs
by which members of the G protein-coupled receptor (GPCR) family respond to neurotransmitters in the brain
- 📰 GPCR Weekly News, January 30 to February 5, 2023
GPCR Binders, Drugs, and more Ligands selectively tune the local and global motions of neurotensin receptor Reviews, GPCRs, and more Understanding Neuropeptide Transmission in the Brain by Optical Uncaging and
- Illuminating the draggable GPCR-ome
Bryan Roth There are 10 open tickets available. Get yours now!
- In Vitro and In Silico Characterization of Kurarinone as a Dopamine D 1A Receptor Antagonist and ...
Alterations in the expression and/or activity of brain G-protein-coupled receptors (GPCRs) such as dopamine Since studies have indicated that flavonoids can target brain GPCRs and provide neuroprotection via inhibition
- Chemogenetic stimulation of the G i pathway in astrocytes suppresses neuroinflammation
functional role of the astrocytic Gi pathway is not clear, as the literature is conflicting depending on the brain between enhanced calcium transients and the inflammatory phenotype of astrocytes observed in the inflamed brain
- AELIS PHARMA launches their IPO for €25 million
fundraising gives us the means to achieve our ambitions: to become a leading player in the field of brain
- Neurotransmitters: Potential Targets in Glioblastoma
September 2022 "For decades, glioblastoma multiforme (GBM), a type of the most lethal brain tumor, has
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
Exclusive access to private groups Over 30 recorded talks from Symposia - that's a lot of brain food To Design Novel GPCR- Targeted Antibody Therapeutics Using Generative AI Zombie Fungi Hijack Hosts’ Brains punctata GPCRs in Neuroscience Neuron specific quantitation of Gαolf expression and signaling in murine brain
- Emerging approaches for decoding neuropeptide transmission
in high-resolution techniques to investigate peptidergic transmission and expression throughout the brain
- Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin recept
This compound has vastly reduced brain penetration and is devoid of significant off-target liability.
- Adenosine receptor signalling in Alzheimer's disease
The adenosine A1 and A2A receptors are expressed in the human brain and have a proposed involvement in